Summary
- Current Price
- As of today, RNXT price is $1.40, up +11.11% on
- Current Price All-Time High
- RNXT price is currently -91.64% below its historical high of $16.74 set on
- Market Cap
- RNXT current market cap is $63M, up +39.04% over the past 365 days
- Revenue
- RNXT current annual revenue is $1.12M, up +2511.63% year-over-year
- Next Earnings
- As of today, the next earnings release for RNXT has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | RenovoRx, Inc. |
| Ticker | NASDAQ: RNXT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | renovorx.com |
| Employees | 10 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.40 | ||
| Price, 1D Change | +11.11% | |
| $63M | ||
| - | ||
| - | ||
| 1.42 | ||
| $1.12M | ||
| Revenue, 1Y Change | +2,511.63% | |
| -$0.32 | ||
| EPS, 1Y Change | +20.14% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.32 | ||
| EPS Estimate | -$0.31 | N/A |
| EPS Est. Change | +1.93% | N/A |
| $1.12M | ||
| Revenue Estimate | $3.21M | N/A |
| Revenue Est. Change | +185.49% | N/A |
| $1.40 | ||
| Price Target | $5.56 | - |
| Price Tgt. Change | +297.14% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.41 | -$0.40 | +2.27% | |
| -$0.32 | -$0.32 | +0.19% | |
| -$0.31 | N/A | +1.93% | |
| -$0.15 | N/A | +52.55% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $43.00K | - | |
| $1.30M | $1.12M | -13.93% | |
| $3.21M | N/A | +185.49% | |
| $12.29M | N/A | +994.59% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +12.90% | ||
| -24.32% | ||
| +39.04% | ||
| +219.38% | ||
| +2,511.63% | ||
| +100.00% | ||
| +20.14% | ||
| +71.07% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.40 | ||
| $0.94 | ||
| $0.95 | ||
| $0.98 | ||
| $0.99 | ||
| $0.09 | ||
| 1.42 | ||
| $0.08 | ||
| 78.50 | ||
| 97.19% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.12M | ||
| -$0.32 | ||
| $796.00K | ||
| 70.88% | ||
| -$12.51M | ||
| -1,113.98% | ||
| -$11.17M | ||
| -994.48% | ||
| -$12.51M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 4.02 | ||
| 3.93 | ||
| - | ||
| 3 | ||
| -0.68 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 42.43 | ||
| 5.61 | ||
| -3.96 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $5.42M | ||
| $7.02M | ||
| $8.14M | ||
| $7.89M | ||
| $2.72M | ||
| $1.96M | ||
| $212.00K | ||
| $105.00K | ||
| $799.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $12.29M | ||
| $13.31M | ||
| $327.00K | ||
| $0.00 | ||
| $2,000.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$10.97M | ||
| -$2,000.00 | ||
| $10.85M | ||
| $2,000.00 | ||
| -$10.98M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RNXT
FAQ
- What is the ticker symbol for RenovoRx, Inc.?
- The ticker symbol for RenovoRx, Inc. is NASDAQ:RNXT
- Does RenovoRx, Inc. pay dividends?
- No, RenovoRx, Inc. does not pay dividends
- What sector is RenovoRx, Inc. in?
- RenovoRx, Inc. is in the Healthcare sector
- What industry is RenovoRx, Inc. in?
- RenovoRx, Inc. is in the Biotechnology industry
- What country is RenovoRx, Inc. based in?
- RenovoRx, Inc. is headquartered in United States
- When did RenovoRx, Inc. go public?
- RenovoRx, Inc. initial public offering (IPO) was on August 26, 2021
- Is RenovoRx, Inc. in the S&P 500?
- No, RenovoRx, Inc. is not included in the S&P 500 index
- Is RenovoRx, Inc. in the NASDAQ 100?
- No, RenovoRx, Inc. is not included in the NASDAQ 100 index
- Is RenovoRx, Inc. in the Dow Jones?
- No, RenovoRx, Inc. is not included in the Dow Jones index
- When was RenovoRx, Inc. last earnings report?
- RenovoRx, Inc.'s most recent earnings report was on August 14, 2025
- When does RenovoRx, Inc. report earnings?
- The date for RenovoRx, Inc.'s next earnings report has not been announced yet
Data Sources & References
- RNXT Official Website renovorx.com
- RNXT Profile on Yahoo Finance finance.yahoo.com/quote/RNXT
- RNXT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rnxt